SHYFT Analytics Delivers Transformational Insights to Life Sciences With Next Generation Real World Evidence Analytics Platform WALTHAM, MA–(Marketwired – Jul 29, 2015) – SHYFT Analytics, a leader in cloud-based data and guided analytics solutions for the global life sciences industry, today announced formal availability of its next generation Real World Evidence (RWE) Analytics Solution to […]

Many of the drugs that are sold over-the-counter (OTC) began life as prescription medications. Anti-ulcer/heartburn drugs such as the histamine H2 antagonist, Zantac, and the proton-pump inhibitor, Prilosec, were first marketed as prescription only drugs more than 25 years ago, yet now are readily available OTC. The same can be said for anti-allergy medications such […]

Mereo BioPharma Group Ltd (“Mereo”), a recently-formed specialty biopharmaceutical company, announces that it has successfully raised $119m (c. £76.5m), gross, from blue chip institutional investors and simultaneously acquired a portfolio of three innovative clinical-stage development programs from Novartis Pharmaceuticals. Novartis, through the shares issued in consideration for the acquisition of products, will also hold an […]

Sanofi said on Wednesday a first late-stage Phase III study of its LixiLan diabetes drug had met its main target, while another would be completed at the end of the third quarter. LixiLan consists of a single-injection combination of Lyxumia, a drug developed with Danish drugmaker Zealand Pharma, and Sanofi’s Lantus. It targets patients suffering […]

Merck & Co. (MRK) enhanced its oncology pipeline with the $605 million acquisition of privately-held Israeli biotech company cCam Biotherapeutics, which is focused on the development of cancer immunotherapies.   With the acquisition of the five-year-old cCam, Merck will add that company’s lead product CM-24, a monoclonal antibody (mAb) that targets CEACAM1, a “checkpoint” protein […]

French drugmaker Sanofi (SASY.PA) said on Tuesday it was committing up to $2.17 billion to a collaboration with its long-time partner Regeneron Pharmaceuticals (REGN.O) in the hot area of cancer immunotherapy. Sanofi will make an upfront payment of $640 million to Regeneron and the U.S. biotech company will get up to $375 million more if certain […]

Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise “good” HDL cholesterol and lower “bad” LDL cholesterol, acting on the recommendation of a data monitoring committee. The independent panel of scientific advisors made its recommendation after taking an interim look at data from the […]

DUBLIN, IRELAND–(Marketwired – Jul 27, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced a collaboration with Fox Chase Cancer Center to study ACTIMMUNE (interferon gamma-1b) in combination with PD-1/PD-L1 inhibitors in various forms […]

DUBLIN and EVANSTON, Ill., July 26, 2015 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Naurex Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system, today announced that they have entered into a definitive agreement under which Allergan will acquire Naurex in an all-cash transaction. […]

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Revolade® (eltrombopag), a Novartis product, for the treatment of adult patients with acquired severe aplastic anemia (SAA) who were either refractory to prior immunosuppressive therapy (IST) or […]